These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16238783)

  • 1. Multi-dimensional phenotyping: towards a new taxonomy for airway disease.
    Wardlaw AJ; Silverman M; Siva R; Pavord ID; Green R
    Clin Exp Allergy; 2005 Oct; 35(10):1254-62. PubMed ID: 16238783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multiple dimensions of airways disease: targeting treatment to clinical phenotypes.
    Shirtcliffe P; Weatherall M; Travers J; Beasley R
    Curr Opin Pulm Med; 2011 Mar; 17(2):72-8. PubMed ID: 21150622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic obstructive pulmonary disease: knowing what we mean, meaning what we say.
    Joshi JM
    Indian J Chest Dis Allied Sci; 2008; 50(1):89-95. PubMed ID: 18610693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The A to E of airway disease.
    Pavord ID; Wardlaw AJ
    Clin Exp Allergy; 2010 Jan; 40(1):62-7. PubMed ID: 20205696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic similarities and differences between asthma and chronic obstructive pulmonary disease.
    Mauad T; Dolhnikoff M
    Curr Opin Pulm Med; 2008 Jan; 14(1):31-8. PubMed ID: 18043273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The definition and diagnosis of asthma.
    Hargreave FE; Nair P
    Clin Exp Allergy; 2009 Nov; 39(11):1652-8. PubMed ID: 19622089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asthma phenotypes.
    Kiley J; Smith R; Noel P
    Curr Opin Pulm Med; 2007 Jan; 13(1):19-23. PubMed ID: 17133120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occupational health and general practice: from opportunities lost to opportunities capitalised?
    van Weel C; Orbon K; van der Gulden J; Buijs P; Folgering H; Thoonen B; Schermer T
    Med Lav; 2006; 97(2):288-94. PubMed ID: 17017361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of animal models in the pharmacological evaluation of emerging anti-inflammatory agents for the treatment of COPD.
    Fox JC; Fitzgerald MF
    Curr Opin Pharmacol; 2009 Jun; 9(3):231-42. PubMed ID: 19356979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reclassification of asthma based on subphenotypes.
    Green RH; Brightling CE; Bradding P
    Curr Opin Allergy Clin Immunol; 2007 Feb; 7(1):43-50. PubMed ID: 17218810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic obstructive pulmonary disease in a new concept.
    Murărescu ED; Mitrofan EC; Mihailovici MS
    Rom J Morphol Embryol; 2007; 48(3):207-14. PubMed ID: 17914487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical asthma syndromes and important asthma mimics.
    King CS; Moores LK
    Respir Care; 2008 May; 53(5):568-80; discussion 580-2. PubMed ID: 18426611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How much do we know about atopic asthma: where are we now?
    Ying S; Zhang G; Gu S; Zhao J
    Cell Mol Immunol; 2006 Oct; 3(5):321-32. PubMed ID: 17092429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophilic airway disorders.
    Scott KA; Wardlaw AJ
    Semin Respir Crit Care Med; 2006 Apr; 27(2):128-33. PubMed ID: 16612763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal symptoms, airway obstruction and disease severity in chronic obstructive pulmonary disease.
    Hurst JR; Kuchai R; Michael P; Perera WR; Wilkinson TM; Wedzicha JA
    Clin Physiol Funct Imaging; 2006 Jul; 26(4):251-6. PubMed ID: 16836700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models of asthma: innovative methods of lung research and new pharmacological targets.
    Braun A; Tschernig T
    Exp Toxicol Pathol; 2006 Jun; 57 Suppl 2():3-4. PubMed ID: 16584873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosolized phosphoinositide 3-kinase gamma/delta inhibitor TG100-115 [3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease.
    Doukas J; Eide L; Stebbins K; Racanelli-Layton A; Dellamary L; Martin M; Dneprovskaia E; Noronha G; Soll R; Wrasidlo W; Acevedo LM; Cheresh DA
    J Pharmacol Exp Ther; 2009 Mar; 328(3):758-65. PubMed ID: 19056934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.